Research: HPV vaccine is safe RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
New method for toxicological assessment of perfluoro mixtures Perfluoro (PFAS) is a group of substances that contains PFOS, PFOA and GenX. Perfluoro substances often occur as pollution in ground water and drinking water.
New Director-General Hans Brug starts at RIVM After the approval of his nomination on the proposal of Minister Ollongren of the Interior and Kingdom Relations on June 1 of this year, Professor J.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a
Large increase in legionellosis in the Netherlands The Municipal Public Health Services (GGD) received 561 reports of legionellosis over the past year. Never before has RIVM registered as many reports of this disease as in the past year.
Dutch health similar to health in neighbouring countries The health of the Dutch population is broadly in line with that of our neighbours.
Risk assessment method for gene drives RIVM and partner organisations from England, Germany and Belgium have developed a method to assess the risks of gene drives in laboratories.
Director-general André van der Zande receives Royal honours On Thursday, June 28th, our departing director-general André van der Zande received a Royal decoration from the Dutch Minister of Health, Welfare and Sport, Hugo de Jonge.
Antibiotics are often used correctly, but improvements are still possible General practitioners in the Netherlands are prescribing antibiotics less frequently. No drop has been observed in hospitals.